Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. The team showed that virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors. In a mouse model, the nanoparticle-based vaccine was able to partially or completely suppress HPV-related tumors.



Summary

Researchers at the DKFZ and Heidelberg University have created a promising cancer therapeutic vaccination concept using virus peptides attached to silica nanoparticles. This innovative approach stimulates the immune system, specifically T-cells, to target and fight HPV-related tumors. Testing in a mouse model revealed that the nanoparticle-based vaccine successfully suppressed HPV-related tumor growth, in some cases even leading to complete tumor regression. This study suggests a potential new avenue for developing effective vaccines against cancers caused by HPV infections.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer